Literature DB >> 3882374

Expression of a cloned human fibrinogen cDNA in Escherichia coli: synthesis of an A alpha polypeptide.

S T Lord.   

Abstract

The construction of a plasmid, p166.9, for the controlled synthesis of the A alpha-chain of human fibrinogen in Escherichia coli is described. The plasmid combines the tac promoter, constructed for controlled high-level peptide expression, with the promoter and signal peptide codons from an E. coli plasmid beta-lactamase gene and a cDNA of the A alpha-chain of human fibrinogen. The tac promoter is repressed in lacIQ strains of E. coli and induced by isopropylthio-beta-D-galactoside (IPTG). Protein blot analysis of lysates of cells carrying p166.9 demonstrates the IPTG-dependent synthesis of polypeptides which cross react with antisera to the A alpha-chain of human fibrinogen. The largest and predominant species corresponds to an apparent molecular weight of 63,000. When the cell growth media or cell lysates are treated with thrombin, the enzyme which normally releases fibrinopeptide A (FPA) from the A alpha-chain, FPA-like peptides are detectable by radioimmunoassay with antiserum prepared against human FPA. Thrombin-treated cell growth media prepared 4 hr after IPTG induction contained 340 ng/ml of FPA-like material; using a mass ratio of 40 for FPA to A alpha, this indicates that the A alpha-peptide concentration in the culture media is 13 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882374     DOI: 10.1089/dna.1985.4.33

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  7 in total

Review 1.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

2.  Fibrinogen is a ligand for the Staphylococcus aureus microbial surface components recognizing adhesive matrix molecules (MSCRAMM) bone sialoprotein-binding protein (Bbp).

Authors:  Vanessa Vazquez; Xiaowen Liang; Jenny K Horndahl; Vannakambadi K Ganesh; Emanuel Smeds; Timothy J Foster; Magnus Hook
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

3.  The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation.

Authors:  Caroline V Bamford; J Christopher Fenno; Howard F Jenkinson; David Dymock
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

4.  Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis.

Authors:  Ho Seong Seo; Rong Mu; Brandon J Kim; Kelly S Doran; Paul M Sullam
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

5.  Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen.

Authors:  Evelyn J Walsh; Helen Miajlovic; Oleg V Gorkun; Timothy J Foster
Journal:  Microbiology (Reading)       Date:  2008-02       Impact factor: 2.777

6.  Inhibition of Fibrinolysis by Streptococcal Phage LysinSM1.

Authors:  Hyun Jung Ji; Yong Zhi; Ji Hee Lee; Ki Bum Ahn; Ho Seong Seo; Paul M Sullam
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

7.  Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae.

Authors:  Ho Seong Seo; George Minasov; Ravin Seepersaud; Kelly S Doran; Ievgeniia Dubrovska; Ludmilla Shuvalova; Wayne F Anderson; Tina M Iverson; Paul M Sullam
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.